Ascites Hepatic: Clinical Trials

2 trials for Ascites Hepatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Empagliflozin as a Novel Therapy in Refractory Ascites
Empagliflozin 10 MG, Diuretics - Ascites Hepatic
Phase 2 / Phase 3CompletedAlexandria University422022-04-212022-11-29
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
Terlipressin acetate continuous infusion - Cirrhosis, Ascites Hepatic
Phase 2CompletedBioVie Inc.62017-07-152021-07-13

Narrower conditions

Fibrosis (1)

Broader conditions

Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Diuretics (1)  ·  Terlipressin (1)  ·  empagliflozin (1)

Sponsors

Alexandria University (1)  ·  BioVie Inc. (1)

Countries

Egypt (1)  ·  United States (1)

Top investigators

Patrick Yeramian, MD (1)